These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3114581)

  • 1. L-dihydroxyphenylalanine-induced asymmetric changes in striatal uric acid peak: determination by in vivo electrochemical detection in rats with unilateral nigrostriatal lesions.
    Togasaki DM; Young JG; Knott PJ
    Life Sci; 1987 Sep; 41(11):1361-7. PubMed ID: 3114581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between loss of dopamine nerve terminals, striatal [3H]spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats.
    Heikkila RE; Shapiro BS; Duvoisin RC
    Brain Res; 1981 May; 211(2):285-92. PubMed ID: 7237124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis.
    Zetterström T; Herrera-Marschitz M; Ungerstedt U
    Brain Res; 1986 Jun; 376(1):1-7. PubMed ID: 3087581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The grid-walking test: assessment of sensorimotor deficits after moderate or severe dopamine depletion by 6-hydroxydopamine lesions in the dorsal striatum and medial forebrain bundle.
    Chao OY; Pum ME; Li JS; Huston JP
    Neuroscience; 2012 Jan; 202():318-25. PubMed ID: 22142899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
    Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
    Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated administration of the monoamine reuptake inhibitor BTS 74 398 induces ipsilateral circling in the 6-hydroxydopamine lesioned rat without sensitizing motor behaviours.
    Lane EL; Cheetham SC; Jenner P
    Eur J Neurosci; 2005 Jan; 21(1):179-86. PubMed ID: 15654855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
    Xu K; Dluzen DE
    J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid levels and dopamine transmission in rat striatum: diurnal changes and effects of drugs.
    O'Neill RD
    Brain Res; 1990 Jan; 507(2):267-72. PubMed ID: 2337766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-dopa induced increases in brain uric acid in an animal model of Parkinson's disease: a relationship to behavioral activation.
    Pinheiro-Carrera M; Tomaz C; Huston JP; Dai H; Carey RJ
    Life Sci; 1994; 55(13):991-7. PubMed ID: 8084215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The decarboxylation of DOPA in the parkinsonian brain: in vivo studies on an animal model.
    Hefti F; Melamed E; Wurtman RJ
    J Neural Transm Suppl; 1980; (16):95-101. PubMed ID: 6776238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.
    Masuo Y; Montagne MN; Pélaprat D; Scherman D; Rostène W
    Brain Res; 1990 Jun; 520(1-2):6-13. PubMed ID: 2169955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compensatory bilateral changes in dopamine turnover after striatal kainate lesion.
    Andersson K; Schwarcz R; Fuxe K
    Nature; 1980 Jan; 283(5742):94-6. PubMed ID: 7188627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha(2) adrenoceptor antagonist idazoxan alleviates L-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats.
    Buck K; Voehringer P; Ferger B
    J Neurochem; 2010 Jan; 112(2):444-52. PubMed ID: 19895663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased response to intrastriatal L(+)-2-amino-4-phosphonobutyrate (L-AP4) in unilateral 6-hydroxydopamine-lesioned rats.
    Zhang C; Albin RL
    Exp Neurol; 2000 Oct; 165(2):278-84. PubMed ID: 10993688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
    Abercrombie ED; Bonatz AE; Zigmond MJ
    Brain Res; 1990 Aug; 525(1):36-44. PubMed ID: 2123121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
    Jackson D; Abercrombie ED; Zigmond MJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR; Abercrombie ED
    J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decarboxylation of exogenous L-3,4-dihydroxyphenylalanine in rat striatum as studied by in vivo voltammetry.
    Nakazato T; Akiyama A
    J Neurochem; 1992 Jan; 58(1):121-7. PubMed ID: 1727424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.